JULIE NANGIA to Young Adult
This is a "connection" page, showing publications JULIE NANGIA has written about Young Adult.
Connection Strength
0.016
-
TBCRC023: A Randomized Phase II Neoadjuvant Trial of Lapatinib Plus Trastuzumab Without Chemotherapy for 12 versus 24 Weeks in Patients with HER2-Positive Breast Cancer. Clin Cancer Res. 2020 02 15; 26(4):821-827.
Score: 0.016